Back
Matinas BioPharma Holdings Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
23
MTNB
Matinas BioPharma Holdings
Last Price:
$0.54
Seasonality Move:
13.52%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.-
The current trend is relatively stagnant and MTNB is experiencing selling pressure, which indicates risk of future bearish movement.
Matinas BioPharma Holdings Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.56 | Sell |
| 20-day SMA: | 0.58 | Sell |
| 50-day SMA: | 1.27 | Sell |
| 200-day SMA: | 6.24 | Sell |
| 8-day EMA: | 0.55 | Sell |
| 20-day EMA: | 0.63 | Sell |
| 50-day EMA: | 1.35 | Sell |
| 200-day EMA: | 5.54 | Sell |
Matinas BioPharma Holdings Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 30.96 | Sell |
| Chaikin Money Flow: | -12469 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.55 - 0.61) | Sell |
| Bollinger Bands (100): | (0.73 - 5.19) | Sell |
Matinas BioPharma Holdings Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Matinas BioPharma Holdings Stock
Is Matinas BioPharma Holdings Stock a Buy?
-
Matinas BioPharma Holdings share price is 0.53 while MTNB 8-day simple moving average is 0.56, which is a Sell signal.
-
The stock price of MTNB is 0.53 while Matinas BioPharma Holdings 20-day SMA is 0.58, which makes it a Sell.
-
Matinas BioPharma Holdings 50-day simple moving average is 1.27 while MTNB share price is 0.53, making it a Sell technically.
-
MTNB stock price is 0.53 and Matinas BioPharma Holdings 200-day simple moving average is 6.24, creating a Sell signal.
MTNB Technical Analysis vs Fundamental Analysis
Sell
23
Matinas BioPharma Holdings (MTNB)
is a Sell
Is Matinas BioPharma Holdings a Buy or a Sell?
-
Matinas BioPharma Holdings stock is rated a SellThe current Matinas BioPharma Holdings [MTNB] share price is $0.53. The Score for MTNB is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Matinas BioPharma Holdings Stock Info
Market Cap:
2.7M
Price in USD:
0.53
Share Volume:
34.6K
Matinas BioPharma Holdings 52-Week Range
52-Week High:
21.50
52-Week Low:
0.50
Sell
23
Matinas BioPharma Holdings (MTNB)
is a Sell
Matinas BioPharma Holdings Share Price Forecast
-
What is the Matinas BioPharma Holdings stock price today?The Matinas BioPharma Holdings stock price is 0.53 USD today.
-
Will MTNB stock go up or go down?Matinas BioPharma Holdings> share price is forecast to RISE/FALL based on technical indicators
-
Is Matinas BioPharma Holdings overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Matinas BioPharma Holdings is overvalued.
Is Matinas BioPharma Holdings Stock a Buy?
-
Matinas BioPharma Holdings share price is 0.53 while MTNB 8-day exponential moving average is 0.55, which is a Sell signal.
-
The stock price of MTNB is 0.53 while Matinas BioPharma Holdings 20-day EMA is 0.63, which makes it a Sell.
-
Matinas BioPharma Holdings 50-day exponential moving average is 1.35 while MTNB share price is 0.53, making it a Sell technically.
-
MTNB stock price is 0.53 and Matinas BioPharma Holdings 200-day simple moving average is 5.54, creating a Sell signal.
Fundamental Analysis of Matinas BioPharma Holdings
Is Matinas BioPharma Holdings a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and an increase next year of $1.06 per share.
Technical Analysis of Matinas BioPharma Holdings
Should I short Matinas BioPharma Holdings stock?
-
MTNB Moving Average Covergence Divergence (MACD) indicator is -0.17, suggesting Matinas BioPharma Holdings is a Sell
-
Matinas BioPharma Holdings Relative Strength Index (RSI) is 30.96, which suggest Matinas BioPharma Holdings is oversold
-
The Bollinger Bands (25) for Matinas BioPharma Holdings is (0.55 - 0.61), which suggest Matinas BioPharma Holdings is a Sell
-
The Bollinger Bands (100) for Matinas BioPharma Holdings is (0.73 - 5.19), which suggest Matinas BioPharma Holdings is a Sell
* Matinas BioPharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.